Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Intangibles (2016 - 2025)

Fortress Biotech has reported Intangibles over the past 11 years, most recently at $27.6 million for Q4 2025.

  • Quarterly results put Intangibles at $27.6 million for Q4 2025, down 13.36% from a year ago — trailing twelve months through Dec 2025 was $27.6 million (down 13.36% YoY), and the annual figure for FY2025 was $27.6 million, down 13.36%.
  • Intangibles for Q4 2025 was $27.6 million at Fortress Biotech, down from $28.7 million in the prior quarter.
  • Over the last five years, Intangibles for FBIO hit a ceiling of $31.9 million in Q4 2024 and a floor of $397000.0 in Q2 2021.
  • Median Intangibles over the past 5 years was $24.0 million (2023), compared with a mean of $22.1 million.
  • Biggest five-year swings in Intangibles: plummeted 97.29% in 2021 and later soared 7315.62% in 2022.
  • Fortress Biotech's Intangibles stood at $397000.0 in 2021, then soared by 6750.63% to $27.2 million in 2022, then dropped by 25.41% to $20.3 million in 2023, then soared by 57.06% to $31.9 million in 2024, then decreased by 13.36% to $27.6 million in 2025.
  • The last three reported values for Intangibles were $27.6 million (Q4 2025), $28.7 million (Q3 2025), and $29.7 million (Q2 2025) per Business Quant data.